As of May 2026

Coverage varies by plan. This information summarizes publicly-disclosed formulary information as of the date above. Always confirm with your insurer.

Does Blue Cross Blue Shield Cover Ozempic, Wegovy, Mounjaro, and Zepbound?

Blue Cross Blue Shield (BCBS) is not a single insurer — it is a federation of 34 independent regional companies, which makes answering coverage questions more complex than for a unified insurer like Aetna. Ozempic and Mounjaro for diabetes are broadly covered across BCBS affiliates. Coverage for Wegovy and Zepbound for weight loss varies substantially: the Federal Employee Program and some commercial group plans cover them, while other affiliates and plan types have excluded them as of 2026. This page summarizes what BCBS affiliates and the FEP formulary publicly disclose as of May 2026.

Important: BCBS coverage is affiliate-specific. BCBS of Texas, BCBS of Massachusetts, Anthem BCBS, and the Federal Employee Program each maintain separate formularies. This page summarizes published policies across major affiliates — always verify with your specific BCBS company.

Ozempic (semaglutide) — Type 2 Diabetes

Generally Covered
Coverage Status
Yes — for diabetes
Formulary Tier
Tier 2–3 (varies by affiliate)
Prior Auth Required
Yes
Typical OOP (with coverage)
$60–$200/mo

Most BCBS affiliates cover Ozempic for Type 2 diabetes on commercial group plans. Nevada Anthem BCBS covers Ozempic at Tier 2 for diabetes with prior authorization and step therapy (metformin first), per Word & Brown's May 2026 carrier summary. California Anthem BCBS reclassified all GLP-1 drugs to Tier 4 specialty status as of January 2025, meaning higher cost-sharing even for diabetes coverage on ACA plans. The BCBS Federal Employee Program covers Ozempic for diabetes; the specific tier depends on whether you have FEP Blue Standard or FEP Blue Basic. Ozempic is not covered by any BCBS plan when prescribed solely for weight loss. Novo Nordisk's NovoCare savings program may reduce costs to $25/month for eligible commercially insured patients.

Wegovy (semaglutide) — Weight Management

Highly Variable
Coverage Status
Varies by affiliate
Formulary Tier (FEP)
Tier 3 (specialty)
Prior Auth Required
Yes — always
Typical OOP (FEP Basic)
~$783/mo (60% coinsurance)

Wegovy coverage under BCBS depends entirely on which affiliate and plan type you have. The BCBS Federal Employee Program (FEP) covers Wegovy with prior authorization — FEP Blue Basic places it on Tier 3 with 60% coinsurance (the member pays 60%), making out-of-pocket cost approximately $783/month for the 0.25 mg dose at 2026 list prices, per FEP member reports. FEP Blue Standard covers Wegovy with 30% coinsurance or a $100 specialty copay depending on plan version. BCBS of Massachusetts announced in late 2025 that it would no longer cover GLP-1 medications indicated primarily for obesity starting in 2026 for members on the Standard Formulary, per the BCBS MA provider fact sheet — though Harvard-sponsored BCBS plans administered through Express Scripts are not affected. Anthem BCBS multi-state plans are expanding weight-loss GLP-1 coverage in 2026 but typically require step therapy (Contrave or Saxenda trial before Wegovy). Blue Shield of California required prior authorization for medical necessity starting January 2025 for PPO and HMO members, per Blue Shield CA's published fact sheet.

Mounjaro (tirzepatide) — Type 2 Diabetes

Generally Covered
Coverage Status
Yes — for diabetes
Formulary Tier
Tier 2 (NV); varies elsewhere
Prior Auth Required
Yes
Typical OOP (with coverage)
$60–$200/mo

Most BCBS affiliates cover Mounjaro for Type 2 diabetes. Nevada Anthem BCBS explicitly lists Mounjaro at Tier 2 for diabetes, with prior authorization required and step therapy (metformin first), per the Word & Brown carrier summary (May 2026). The BCBS Federal Employee Program covers Mounjaro for diabetes under specialty pharmacy rules. BCBS of Massachusetts covers Mounjaro for diabetes but announced it would no longer cover GLP-1s indicated primarily for obesity — Mounjaro's diabetes indication is unaffected. Some affiliates require notification-only rather than full prior authorization for Mounjaro for short-term diabetes use; others require full PA with step therapy documentation. Mounjaro is not covered by any BCBS plan when prescribed off-label for weight loss alone. Eli Lilly's Lilly Savings Card may reduce costs to $25/month for eligible commercially insured patients.

Zepbound (tirzepatide) — Weight Management

Often Excluded
Coverage Status
Limited / Excluded
Formulary Tier (Anthem CT)
Tier 2 with PA
FEP Blue Basic
Not covered
Typical OOP (without coverage)
~$1,080/mo list price

Zepbound coverage under BCBS is the most restricted of the four GLP-1 medications. The BCBS FEP Blue Basic plan does not cover Zepbound; members are required to try both Wegovy and Saxenda before Zepbound can be considered, per FEP member accounts and FEP formulary documentation. The FEP program uses CVS Caremark, which has a Novo Nordisk partnership — this may structurally favor Wegovy over Zepbound. BCBS of Massachusetts explicitly excluded Zepbound from coverage for weight loss starting 2026, along with Saxenda and Wegovy for obesity indications. Anthem BCBS in Connecticut lists Zepbound at Tier 2 on the 2026 Essential Drug List with prior authorization and benefit design requirements, per Anthem CT's published formulary — one of the more favorable BCBS placements. BCBS of Texas coverage is largely employer-dependent. Nevada BCBS does not cover weight-loss GLP-1s on large group fully insured plans. Members with obstructive sleep apnea documentation may be able to obtain Zepbound coverage where it is otherwise excluded, as OSA represents a separate FDA-approved indication. Eli Lilly's Lilly Savings Card does not apply when insurance is billed — it is available for self-pay patients.

BCBS Affiliate GLP-1 Coverage at a Glance (May 2026)

Affiliate Ozempic Wegovy Mounjaro Zepbound
BCBS FEP Standard ✓ Diabetes PA required ✓ Diabetes Step therapy
BCBS FEP Basic ✓ Diabetes Tier 3 (60% OOP) ✓ Diabetes Excluded
Anthem BCBS (multi-state) ✓ Diabetes Select plans ✓ Diabetes Select plans
BCBS Massachusetts ✓ Diabetes Excluded (2026) ✓ Diabetes Excluded (2026)
BCBS Illinois ✓ Diabetes Select plans ✓ Diabetes Select plans
Anthem BCBS Nevada ✓ Tier 2 Not covered ✓ Tier 2 Not covered

Sources: Word & Brown (May 2026), BCBS MA Provider Fact Sheet, Anthem CT 2026 Drug List. Coverage can change — confirm with your insurer.

How to Check Your Specific BCBS Plan

Because BCBS is a federation of independent companies, your first step is identifying which BCBS affiliate administers your plan — it is printed on your member ID card. Then confirm coverage directly with that company.

  1. Look at your insurance card to identify your specific BCBS affiliate (e.g., Anthem, BCBS of Illinois, Blue Shield of California, FEP Blue).
  2. Call the member services number on the back of your card and ask to speak with Pharmacy Benefits.
  3. Ask specifically: "Is [medication name] covered on my formulary for [diabetes / weight management]?"
  4. Reference the NDC — Ozempic NDC: 0169-4060; Wegovy NDC: 0169-4550; Mounjaro NDC: 0002-1436; Zepbound NDC: 0002-1453.
  5. Ask: "Is prior authorization required, and what documentation must my doctor submit?"
  6. Ask: "Is my plan self-funded or fully insured?" — this affects whether state mandates apply.

If Blue Cross Blue Shield Does Not Cover Your Medication

If your BCBS plan excludes Ozempic, Wegovy, Mounjaro, or Zepbound, these telehealth providers can prescribe GLP-1 medications and ship directly to your door — often with pricing that competes favorably with high-deductible plan out-of-pocket costs.

Advertising disclosure: The telehealth options below are paid sponsors. We may earn a commission when you sign up. This does not affect your pricing. Listing order does not imply medical recommendation. Always consult a licensed healthcare provider.

Peter MDSponsored

Physician-led longevity and weight management. GLP-1 options including Ozempic, Wegovy, Mounjaro, and Zepbound.

- Physician-Led Program
- Ozempic / Wegovy Access
TMates GLP1Sponsored

Direct-to-patient GLP-1 with streamlined intake. Mounjaro and Zepbound available with home delivery.

- Mounjaro / Zepbound
- Home Shipping
Oak LongevitySponsored

Longevity-focused weight management with GLP-1 access including Wegovy and Zepbound programs.

- Wegovy / Zepbound
- Metabolic Care
Trim RxSponsored

Telehealth GLP-1 prescriptions with direct provider consultations. Ozempic and Mounjaro options available.

- Ozempic / Mounjaro
- Home Delivery
HersSponsored

Women's telehealth platform with GLP-1 weight management including Wegovy and Zepbound options.

- Wegovy / Zepbound
- Women's Health

Frequently Asked Questions — BCBS GLP-1 Coverage

Why does BCBS coverage vary so much for GLP-1 medications?

Blue Cross Blue Shield is a federation of 34 independently operated companies — BCBS of Texas, BCBS of Illinois, Anthem BCBS, BCBS of Massachusetts, and the Federal Employee Program each operate as separate insurers with separate formularies, clinical policies, and employer contracts. A policy decision made by BCBS of Massachusetts does not apply to Anthem BCBS in Connecticut. Self-funded employer plans, regardless of which BCBS affiliate administers them, can further customize their own formulary and may include or exclude weight-loss GLP-1s independently of the affiliated insurer's standard formulary.

Does BCBS FEP cover Zepbound?

The BCBS Federal Employee Program (FEP) Blue Basic plan does not cover Zepbound as of 2026. FEP Blue Basic uses CVS Caremark, which has a partnership with Novo Nordisk — this arrangement structurally favors Wegovy (semaglutide) over Zepbound (tirzepatide). For FEP Basic members who cannot tolerate Wegovy or Saxenda and have documentation such as obstructive sleep apnea, a formulary exception may be possible through the FEP prior approval process. FEP Blue Standard members should check their specific formulary, as coverage rules may differ.

Did BCBS of Massachusetts stop covering Wegovy and Zepbound?

Yes, with important caveats. BCBS of Massachusetts announced that starting in 2026, it would only authorize GLP-1 medications for Type 2 diabetes — it will no longer cover GLP-1s indicated primarily for obesity, including Wegovy and Zepbound, even for other FDA-approved conditions such as cardiovascular risk reduction and sleep apnea, for members using the Standard Formulary and Advanced Control Specialty Formulary. However, Harvard-sponsored BCBS and HUGHP plans administered through Express Scripts are not affected by this change and continue covering GLP-1s for weight loss through the ESI EncircleRx program.

What step therapy does BCBS typically require for GLP-1 weight-loss medications?

Step therapy requirements vary by BCBS affiliate. Anthem BCBS multi-state plans commonly require a prior trial of Contrave or Saxenda before approving Wegovy or Zepbound. BCBS of Illinois requires a documented six-month lifestyle intervention and step therapy with Contrave before GLP-1 approval. The FEP Blue Basic plan requires documented failure of both Wegovy and Saxenda before Zepbound is considered. All BCBS affiliates require prior authorization for weight-loss GLP-1s, and most require documentation of BMI criteria (typically 30 or greater, or 27 or greater with a qualifying comorbidity) and evidence of prior lifestyle modifications.

Are there any BCBS plans that offer strong GLP-1 weight-loss coverage in 2026?

The BCBS Federal Employee Program (FEP) Blue Standard offers the most accessible GLP-1 weight-loss coverage within the BCBS system — Wegovy is covered at specialty rates with prior authorization, and the FEP Standard specialty copay is $100 for a 30-day supply or 30% coinsurance. Anthem BCBS's Connecticut Essential Drug List places Zepbound at Tier 2 with prior authorization, making it one of the more favorable Zepbound placements in the BCBS federation. Self-funded employer plans administered by any BCBS affiliate can also opt to cover Wegovy and Zepbound — whether your employer made this election is the most important factor to determine first.

Sources and references: Word & Brown GLP-1 Carrier Summary (May 2026) · BCBS MA GLP-1 Provider Fact Sheet · Blue Shield CA Weight Loss Fact Sheet · Anthem CT 2026 Essential Drug List (PDF) · FEP Blue Formulary (fepblue.org) · NovoCare Savings (novocare.com) · Lilly Savings Card (lillydirect.com)